CVS · Earnings call · 2026Q2T · Full report
Caremark Membership Decline
CVS HEALTH Corp · 2026-08-05 · Importance 51 · Surprise 50 · In source text
Management expects Caremark membership to decline in 2027 as the company takes a disciplined approach to client renewals, underwriting and contracting structures during the transition toward lowest-net-cost pricing. Retention is trending slightly below historical performance and closer to industry norms after CVS recorded more than $6 billion of new sales for 2026, well above its historical average. Health-plan client decisions on renewals and market participation may create additional membership pressure. CVS expects specialty pharmacy execution, high adherence, generic dispensing and solutions such as Cordavis to help offset the impact.
Key facts
- Expect membership declines in Caremark in 2027 due to deliberate underwriting/contracting approach in renewals and product actions and market exits by some health plan customers.
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | negative | probable | — | Expect membership declines in Caremark in 2027 due to deliberate underwriting/contracting approach in renewals and product actions and… |